Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

p186-749t p186-749

Promo Available

Anti-MerTK (Tyr749/753/754) Antibody

PhosphoSolutions

DESCRIPTION

Our Anti-MerTK (Tyr749/753/754) rabbit polyclonal phosphospecific primary antibody from PhosphoSolutions is produced in-house. It detects human, mouse, and rat MerTK Tyr749/753/754 and is antigen affinity purified from pooled serum. It is great for use in WB.

DETAILS

  • Form: Antigen Affinity Purified from Pooled Serum
  • Gene: MERTK
  • Host: Rabbit
  • Rrid: AB_2744537
  • Type: Primary Antibody
  • Buffer: 10 mM HEPES (pH 7.5), 150 mM NaCl, 100 µg per ml BSA and 50% glycerol.
  • Target: MerTK Tyr749/753/754
  • Isotype: IgG
  • Storage: Storage at -20°C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20°C.
  • Shipping: Blue Ice
  • Synonyms: c MER antibody, c mer proto oncogene tyrosine kinase antibody, c-mer antibody, cMER antibody, cmer protooncogene tyrosine kinase antibody, Eyk antibody, MER antibody, MER receptor tyrosine kinase antibody, MERK antibody, MERPEN antibody, Mertk antibody, MERTK c-mer proto-oncogene tyrosine kinase antibody, MERTK_HUMAN antibody, MGC133349 antibody, nmf12 antibody, Nyk antibody, Proto oncogene tyrosine protein kinase MER antibody, Proto oncogene tyrosine protein kinase MER precursor antibody, Proto-oncogene c-Mer antibody, Receptor tyrosine kinase MerTK antibody, RP38 antibody, STK kinase antibody, Tyrosine-protein kinase Mer antibody
  • Clonality: Polyclonal
  • Immunogen: Synthetic phospho-peptide corresponding to amino acid residues surrounding Tyr749/753/754 of human MerTK, conjugated to keyhole limpet hemocyanin (KLH).
  • Expiration: After date of receipt, stable for at least 1 year at -20°C.
  • Specificity: Specific for the ~160 kDa MerTK protein phosphorylated at Tyr749/753/754. The immunolabeling is completely eliminated by treatment with λ-phosphatase. Due to post-translational modifications of the Mer protein, a significant shift in molecular weight is seen from the predicted molecular weight of 110 kDa. For optimal results immunoprecipitation is recommended due to the 91% homology of the related receptor tyrosine kinase, Axl, that runs at ~140 kDa.
  • Applications: WB
  • Ncbi Gene Id: 10461
  • Conjugate Exem: Unconjugated
  • Physical State: Liquid
  • Quality Control: Western blots performed on each lot.
  • Usage Statement: For research use only. Not intended for therapeutic or diagnostic use. Use of all products is subject to our terms and conditions, which can be viewed on our website.
  • Molecular Weight: 160
  • Production Notes: Prepared from pooled rabbit serum by affinity purification via sequential chromatography on phospho and non-phosphopeptide affinity columns.
  • Dilution Range Wb: 1:1000
  • Immunogen Species: Human
  • Species Reactivity: Human, Mouse, and Rat
  • Target Description: Along with Tyro-3 and Axl, Mer is a member of the TAM family of receptor tyrosine kinases (RTKs). The TAM family of RTKs regulates cell proliferation/survival, cell adhesion and migration, and blood clot stabilization processes, along with the regulation of inflammatory cytokine release (Linger et al, 2008). Additionally, the TAM family has been linked to coagulopathy and cancer when altered experimentally or genetically (Linger et al, 2008). Tri-phosphorylation of MerTK at tyr749, tyr753 and tyr754 has been identified as a key target in platelet aggregation for developing a new anti-platelet drug that decreases bleeding complications, which are current side effects of similar drugs on the market today (Zhang et al, 2013). MerTK is also seen as a therapeutic target for treating lymphoblastic leukemias, melanoma, breast, lung, colon, liver, gastric, kidney, ovarian, uterine and brain cancers (Graham et al, 1994). There has recently been increased interest in synthesizing novel ATP-competitive small molecule tyrosine kinase inhibitors to decrease tri-phosphorylation of MerTK at tyr749, tyr753, and tyr754 as a therapeutic target to treat AML (Lee-Sherick et al, 2013).
  • Expected Reactivity: Bovine, Canine, Chicken, Finch, Guinea Pig, Non-Human Primate
  • Uniprot Number Immunogen Species: Q12866
  • Post Translational Modification Type: Phosphorylated
  • Post Translational Modification Residue: Tyr749,753,754

PROMOTION TERMS

Trial Size Available. Limit 1